Child and Adolescent Psychopharmacology in the New Millennium: A Workshop for Academia, Industry, and Government-Reference-Cited by-同舟云学术

Child and Adolescent Psychopharmacology in the New Millennium: A Workshop for Academia, Industry, and Government

Published:2006-03 Issue:3 Volume:45 Page:261-270
ISSN:0890-8567
Container-title:Journal of the American Academy of Child & Adolescent Psychiatry
language:en
Short-container-title:Journal of the American Academy of Child & Adolescent Psychiatry

Author:

DEVEAUGH-GEISS JOSEPH,MARCH JOHN,SHAPIRO MARK,ANDREASON PAUL J.,EMSLIE GRAHAM,FORD LISA M.,GREENHILL LAURENCE,MURPHY DIANNE,PRENTICE ERNEST,ROBERTS ROSEMARY,SILVA SUSAN,SWANSON JAMES M.,VAN ZWIETEN-BOOT BARBARA,VITIELLO BENEDETTO,WAGNER KAREN DINEEN,MANGUM BARRY

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Developmental and Educational Psychology

Reference43 articles.

1. The FDA Modernization Act of 1997: impact on pediatric medicine;Buck;Pediatr Pharmacother,2000

2. The ethical use of placebo in clinical trials involving children;Derivan;J Child Adolesc Psychopharmacol,2004

3. The price of innovation: new estimates of drug development costs;DiMasi;J Health Econ,2003

4. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression;Emslie;Arch Gen Psychiatry,1997

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The needs, challenges, and opportunities from the academic researchers' perspective;Essentials of Translational Pediatric Drug Development;2024

2. Six-Month Market Exclusivity Extensions To Promote Research Offer Substantial Returns For Many Drug Makers;Health Affairs;2017-02

3. Canadian Initiatives and Recommendations;The Science and Ethics of Antipsychotic Use in Children;2015

4. Changing the Outcomes of Pediatric Drug Trials: APNs Making a Difference;Journal of Pediatric Health Care;2013-05

5. Depression;Child and Adolescent Psychiatric Clinics of North America;2012-10